Edgewise Therapeutics Inc
(NAS:EWTX)
$
30.53
0.2 (0.66%)
Market Cap: 2.86 Bil
Enterprise Value: 2.34 Bil
PE Ratio: 0
PB Ratio: 5.60
GF Score: 36/100 Edgewise Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 03:55PM GMT
Release Date Price:
$9.74
(-1.42%)
Jason Zemansky
Bank of America and BofA Securities - Analyst
If everyone can take their seats. I'm very (multiple speakers) okay, should be on. Perfect. Well, good morning, everyone. My name is Jason Zemansky and the new SMid-Cap Biotech Analyst here at BofA. and I'm very pleased this morning to be able to introduce Kevin Koch at Edgewise. Good morning.
Kevin Koch
Edgewise Therapeutics - President, CEO, & Member of Board of Directors
Hi! How are you doing?
Questions & Answers
Jason Zemansky
Bank of America and BofA Securities - Analyst
Perfect. Well, maybe to start more broadly, can you remind us your lead program 5506? How does it work? And how does it impact muscle damage?
Kevin Koch
Edgewise Therapeutics - President, CEO, & Member of Board of Directors
Yes. So (technical difficulty) a little bit lower. Okay, so how it affects muscle damage? So during in Duchenne and Becker muscular dystrophy, they're missing a key structural protein called
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot